Tumor Biology

, Volume 35, Issue 10, pp 9777–9785 | Cite as

Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival

  • Ji Zhou
  • Hui Bi
  • Ping Zhan
  • Cunjie Chang
  • Chunhua Xu
  • Xiaojing Huang
  • Like Yu
  • Xin Yao
  • Jun Yan
Research Article


Heterochromatin protein 1γ (HP1γ), which binds to di- or trimethylated lysine 9 on histone H3 (H3K9), plays an important role in chromatin packaging and gene transcriptional regulation. Recently, HP1γ has been implicated in cancer development. However, its clinical relevance and functional role in non-small cell lung cancer (NSCLC) remain elusive. In this study, we found that HP1γ expression was elevated in NSCLC samples at the messenger RNA (mRNA) level compared to adjacent normal lung tissues. In a cohort of 108 NSCLC patients, HP1γ overexpression is significantly associated with N stage (P = 0.003), pathological tumor–node–metastasis (TNM) stage (P = 0.013), smoking status (P = 0.009), and gender (P = 0.042). Patients with a high level of HP1γ expression showed a poorer overall survival rate than those with low HP1γ expression (P = 0.017). Multivariate analysis revealed that HP1γ expression is an independent prognostic marker. We also found knockdown of HP1γ in A549 and NCI-H1975 cells induced apoptosis accompanied with suppressed cell proliferation and colony formation. Consistently, pro-apoptotic proteins, Bax and GADD45α, were upregulated in response to HP1γ depletion. Altogether, our data suggested that HP1γ plays an important role in promoting NSCLC and may represent a novel prognostic biomarker and therapeutic target for the disease.


HP1γ NSCLC Prognosis Proliferation Apoptosis 



This study was supported by the Ministry of Science and Technology of the People’s Republic of China (2011CB944104, 2010CB945101), the National Natural Science Foundation (81172009, 81372168), and the Doctoral Fund of the Ministry of Education of China (20110091120028). The study was also supported by a grant from the “Twelve-Five Plan,” the Major Program of Nanjing Medical Science and Technique Development Foundation (Molecular Mechanism Study on Metastasis and Clinical Efficacy Prediction of Non-small Cell Lung Cancer) and Third Level Training Program of Young Talent Project of Nanjing Health, Nanjing Medical Science and Technology Development Project (QRX11226), and Young Professionals Foundation of Nanjing Chest Hospital. We also thank Dr. Xin Lou for editing our manuscript.

Conflicts of interest

The authors declare that they have no competing interests.


  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56–63.PubMedGoogle Scholar
  3. 3.
    Liloglou T, Bediaga NG, Brown BR, Field JK, Davies MP. Epigenetic biomarkers in lung cancer. Cancer Lett. 2014;342(2):200–12.CrossRefPubMedGoogle Scholar
  4. 4.
    Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. Biomark Med. 2013;7(1):49–58.CrossRefPubMedGoogle Scholar
  5. 5.
    Mitra S, Das S, Chakrabarti J. Systems biology of cancer biomarker detection. Cancer Biomark. 2013;13(4):201–13.PubMedGoogle Scholar
  6. 6.
    Sandoval J, Peiro-Chova L, Pallardo FV, Garcia-Gimenez JL. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities. Expert Rev Mol Diagn. 2013;13(5):457–71.CrossRefPubMedGoogle Scholar
  7. 7.
    Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, et al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 2006;20(22):3089–103.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    El Gazzar M, Yoza BK, Chen X, Hu J, Hawkins GA, McCall CE. G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance. J Biol Chem. 2008;283(47):32198–208.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Chen MW, Hua KT, Kao HJ, Chi CC, Wei LH, Johansson G, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010;70(20):7830–40.CrossRefPubMedGoogle Scholar
  10. 10.
    Zeng W, Ball Jr AR, Yokomori K. HP1: heterochromatin binding proteins working the genome. Epigenetics. 2010;5(4):287–92.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Fanti L, Pimpinelli S. HP1: a functionally multifaceted protein. Curr Opin Genet Dev. 2008;18(2):169–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Dialynas GK, Vitalini MW, Wallrath LL. Linking Heterochromatin Protein 1 (HP1) to cancer progression. Mutat Res. 2008;647(1–2):13–20.PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Slezak J, Truong M, Huang W, Jarrard D. HP1gamma expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy. BMC Cancer. 2013;13:148.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Takanashi M, Oikawa K, Fujita K, Kudo M, Kinoshita M, Kuroda M. Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am J Pathol. 2009;174(1):309–16.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Zhan P, Shen XK, Qian Q, Wang Q, Zhu JP, Zhang Y, et al. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Oncol Rep. 2012;27(4):1072–8.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn Jr PA, et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 2005;167(6):1763–75.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Choi JD, Park MA, Lee JS. Suppression and recovery of BRCA1-mediated transcription by HP1γ via modulation of promoter occupancy. Nucleic Acids Res. 2012;40(22):11321–38.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Ebrahimi A, Schittenhelm J, Honegger J, Schluesener H. Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors. J Neurosurg. 2013;119(6):1424–31.CrossRefPubMedGoogle Scholar
  19. 19.
    Chen JH, Yeh KT, Yang YM, Chang JG, Lee HE, Hung SY. High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan. Med Oncol. 2013;30(2):513.CrossRefPubMedGoogle Scholar
  20. 20.
    Lukasova E, Koristek Z, Falk M, Kozubek S, Grigoryev S, Kozubek M, et al. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities. J Leukoc Biol. 2005;77(1):100–11.PubMedGoogle Scholar
  21. 21.
    Scholzen T, Endl E, Wohlenberg C, van der Sar S, Cowell IG, Gerdes J, et al. The Ki-67 protein interacts with members of the heterochromatin protein 1 (HP1) family: a potential role in the regulation of higher-order chromatin structure. J Pathol. 2002;196(2):135–44.CrossRefPubMedGoogle Scholar
  22. 22.
    Black JC, Allen A, Van Rechem C, Forbes E, Longworth M, Tschop K, et al. Conserved antagonism between JMJD2A/KDM4A and HP1gamma during cell cycle progression. Mol Cell. 2010;40(5):736–48.CrossRefPubMedGoogle Scholar
  23. 23.
    Wang W, Huper G, Guo Y, Murphy SK, Olson Jr JA, Marks JR. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene. 2005;24(16):2705–14.CrossRefPubMedGoogle Scholar
  24. 24.
    Guo W, Dong Z, Guo Y, Chen Z, Kuang G, Yang Z. Methylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma. Int J Cancer. 2013;133(9):2043–53.CrossRefPubMedGoogle Scholar
  25. 25.
    Higashi H, Vallböhmer D, Warnecke-Eberz U, Hokita S, Xi H, Brabender J, et al. Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer. Anticancer Res. 2006;26(3A):2143–7.PubMedGoogle Scholar
  26. 26.
    Smallwood A, Estève PO, Pradhan S, Carey M. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev. 2007;21(10):1169–78.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Tong T, Ji J, Jin S, Li X, Fan W, Song Y, et al. Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. Mol Cell Biol. 2005;25(11):4488–500.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Jiang T, Soprano DR, Soprano KJ. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells. J Cell Physiol. 2007;212(3):771–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 1994;266(5189):1376–80.CrossRefPubMedGoogle Scholar
  30. 30.
    Tront JS, Hoffman B, Liebermann DA. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res. 2006;66(17):8448–54.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Ji Zhou
    • 1
  • Hui Bi
    • 1
  • Ping Zhan
    • 2
    • 3
  • Cunjie Chang
    • 4
  • Chunhua Xu
    • 2
    • 3
  • Xiaojing Huang
    • 4
  • Like Yu
    • 2
    • 3
  • Xin Yao
    • 1
  • Jun Yan
    • 4
  1. 1.Department of Respiratory MedicineThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  2. 2.The First Department of Respiratory MedicineNanjing Chest HospitalNanjingChina
  3. 3.Clinical Center of Nanjing Respiratory Diseases and ImagingNanjingChina
  4. 4.MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing Biomedical Research InstituteNanjing UniversityNanjingChina

Personalised recommendations